| 2025-11-14 |
详情>>
股本变动：
变动后总股本1937.92万股
变动原因 ▼▲
- 原因：
- From June 30, 2025 to September 30, 2025
Shares issued
|
| 2025-11-14 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.06美元,归母净利润-57.96万美元,同比去年增长-19.98%
|
| 2025-10-09 |
停牌提示：
2025-10-08 19:50:00 停牌:
停牌原因 ▼▲
- 原因：
- Halt - SEC Trading Suspension_x000D_
The Securities and Exchange Commission has suspended trading in this stock.
Halt - News Pending_x000D_
Trading is halted pending the release of material news.
Halt - Additional Information Requested by NASDAQ_x000D_
Trading is halted pending receipt of additional information requested by NASDAQ.
|
| 2025-08-29 |
详情>>
业绩披露：
2025年中报每股收益0.05美元,归母净利润38.41万美元,同比去年增长187.29%
|
| 2025-05-23 |
详情>>
业绩披露：
2025年一季报每股收益-0.08美元,归母净利润-53.62万美元,同比去年增长-6775.48%
|
| 2025-05-23 |
详情>>
业绩披露：
2024年年报每股收益-0.12美元,归母净利润-77.92万美元,同比去年增长-1084.95%
|
| 2025-05-23 |
详情>>
业绩披露：
2023年年报每股收益79.11美元,归母净利润7.91万美元,同比去年增长110.36%
|
| 2024-11-19 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.12美元,归母净利润-48.31万美元,同比去年增长-296.85%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2017-07-24 |
股东大会：
将于2017-08-21召开股东大会
会议内容 ▼▲
- 1.To consider and vote on a proposal to adopt the Agreement and Plan of Merger, dated as of May 21, 2017 (as it may be amended, supplemented or otherwise modified from time to time, the "merger agreement"), by and among Nutrition Parent, LLC, a Delaware limited liability company ("Parent"), Nutrition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent ("Merger Sub"), and Nutraceutical International Corporation, a Delaware corporation ("Nutraceutical" or the "Company"), which we refer to as the "merger proposal;"
2.To consider and vote on a nonbinding, advisory proposal to approve the compensation that may be paid or may become payable to the Company's named executive officers in connection with, or following, the consummation of the merger, which we refer to as the "nonbinding compensation proposal;"
3.To consider and vote on a proposal to adjourn the special meeting to a later date or time, if necessary or appropriate as determined by the Company, to solicit additional proxies if there are insufficient votes at the time of the special meeting or any adjournment or postponement thereof to approve the merger proposal, which we refer to as the "adjournment proposal."
|
| 2017-03-03 |
除权日：
美东时间 2017-03-16 每股派息0.13美元
|
| 2016-12-16 |
股东大会：
将于2017-01-23召开股东大会
会议内容 ▼▲
- 1.Election of two Class I directors, each for a term of three years,
2.Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2017,
3.Advisory vote to approve named executive officer compensation,
4.Any other business that may properly come before the meeting or any adjournment of the meeting.
|
| 2016-12-01 |
除权日：
美东时间 2016-12-16 每股派息0.13美元
|
| 2015-12-18 |
股东大会：
将于2016-01-25召开股东大会
会议内容 ▼▲
- 1.Election of two Class III directors, each for a term of three years;
2.Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2016;
3.Advisory vote to approve named executive officer compensation;
4.Any other business that may properly come before the meeting or any adjournment of the meeting.
|
| 2014-12-19 |
股东大会：
将于2015-01-26召开股东大会
会议内容 ▼▲
- 1.Election of two Class II directors, each for a term of three years;
2.Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2015;
3.Advisory vote to approve named executive officer compensation;
4.Any other business that may properly come before the meeting or any adjournment of the meeting.
|
| 2013-12-23 |
股东大会：
将于2014-01-27召开股东大会
会议内容 ▼▲
- 1. Election of two Class I directors, each for a term of three years;
2. Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2014;
3. Advisory vote to approve named executive officer compensation;
4. Any other business that may properly come before the meeting or any adjournment of the meeting.
|
| 2012-12-21 |
股东大会：
将于2013-01-28召开股东大会
会议内容 ▼▲
- 1.Election of two Class III directors, each for a term of three years
2.Ratification of the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending September 30, 2013
3.Approval of the Nutraceutical International Corporation 2013 Long-Term Equity Incentive Plan
4.Advisory vote to approve named executive officer compensation
5.Any other business that may properly come before the meeting or any adjournment of the meeting.
|
| 2012-12-11 |
除权日：
美东时间 2012-12-19 每股派息1.00美元
|